GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt
· Delayed Price · Currency is EGP 63.10
-0.79 (-1.24%)
At close: Dec 4, 2025
GlaxoSmithKline S.A.E Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,270 | 3,007 | 2,969 | 3,187 | 2,579 | 1,416 | Upgrade
|
| Market Cap Growth | 46.71% | 1.27% | -6.84% | 23.57% | 82.08% | -14.17% | Upgrade
|
| Enterprise Value | 6,192 | 3,430 | 2,758 | 2,079 | 2,840 | 1,603 | Upgrade
|
| Last Close Price | 63.10 | 36.00 | 34.64 | 33.60 | 26.28 | 14.24 | Upgrade
|
| PE Ratio | 53.86 | 17.28 | 49.11 | 4.33 | 16.68 | 50.35 | Upgrade
|
| PS Ratio | 1.41 | 1.00 | 1.33 | 1.75 | 1.42 | 0.71 | Upgrade
|
| PB Ratio | 2.59 | 1.51 | 1.51 | 1.84 | 1.90 | 1.17 | Upgrade
|
| P/TBV Ratio | 2.59 | 1.51 | 1.51 | 2.00 | 2.31 | 1.45 | Upgrade
|
| P/FCF Ratio | - | - | 13.18 | 3.23 | 16.49 | - | Upgrade
|
| P/OCF Ratio | - | - | 9.82 | 3.08 | 13.42 | - | Upgrade
|
| EV/Sales Ratio | 1.66 | 1.15 | 1.23 | 1.14 | 1.57 | 0.81 | Upgrade
|
| EV/EBITDA Ratio | 27.35 | 7.36 | 5.71 | 42.79 | 10.20 | 6.94 | Upgrade
|
| EV/EBIT Ratio | 36.85 | 8.05 | 6.15 | 135.68 | 11.73 | 7.92 | Upgrade
|
| EV/FCF Ratio | -31.25 | - | 12.25 | 2.11 | 18.15 | - | Upgrade
|
| Debt / Equity Ratio | 0.62 | 0.06 | 0.05 | 0.04 | 0.13 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 5.59 | 0.25 | 0.20 | 1.07 | 0.60 | 0.63 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.43 | 0.07 | 1.15 | - | Upgrade
|
| Asset Turnover | 0.91 | 0.83 | 0.66 | 0.65 | 0.80 | 0.89 | Upgrade
|
| Inventory Turnover | 2.35 | 2.51 | 2.46 | 2.57 | 2.31 | 3.15 | Upgrade
|
| Quick Ratio | 0.41 | 0.47 | 1.01 | 0.95 | 0.73 | 0.58 | Upgrade
|
| Current Ratio | 1.53 | 1.82 | 1.88 | 1.76 | 1.53 | 1.44 | Upgrade
|
| Return on Equity (ROE) | 4.97% | 8.79% | 3.27% | -7.38% | 12.03% | 2.32% | Upgrade
|
| Return on Assets (ROA) | 2.55% | 7.38% | 8.32% | 0.34% | 6.66% | 5.62% | Upgrade
|
| Return on Capital (ROIC) | 3.58% | 12.74% | 14.53% | 0.57% | 10.45% | 9.01% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.00% | 20.50% | 22.10% | 0.90% | 17.10% | 16.50% | Upgrade
|
| Earnings Yield | 1.87% | 5.79% | 2.04% | 23.08% | 6.00% | 1.99% | Upgrade
|
| FCF Yield | -3.76% | -17.58% | 7.58% | 30.98% | 6.07% | -3.87% | Upgrade
|
| Dividend Yield | 1.19% | - | 2.17% | - | 2.85% | - | Upgrade
|
| Payout Ratio | 14.36% | 40.05% | 217.67% | 15.10% | 3.61% | 19.84% | Upgrade
|
| Total Shareholder Return | 0.50% | - | 2.17% | - | 2.85% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.